Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-29

Clinical Trial Update: Nalbuphine Versus Morphine for Perioperative Tumor Ablation [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing nalbuphine to morphine for perioperative pain management during tumor ablation; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Zhongda Hospital | Conditions: Nalbuphine Allergy, Ablation | Phase 4 | Status: UNKNOWN